Intraoperative Mass Spectrometry of Tumor Metabolites
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Cairns R, Mak T
. Oncogenic isocitrate dehydrogenase mutations: mechanisms, models, and clinical opportunities. Cancer Discov. 2013; 3(7):730-41.
DOI: 10.1158/2159-8290.CD-13-0083.
View
2.
Liu X, Ide J, Norton I, Marchionni M, Ebling M, Wang L
. Molecular imaging of drug transit through the blood-brain barrier with MALDI mass spectrometry imaging. Sci Rep. 2013; 3:2859.
PMC: 3790202.
DOI: 10.1038/srep02859.
View
3.
Mrugala M
. Advances and challenges in the treatment of glioblastoma: a clinician's perspective. Discov Med. 2013; 15(83):221-30.
View
4.
Tran D, Jensen R
. Treatment-related brain tumor imaging changes: So-called "pseudoprogression" vs. tumor progression: Review and future research opportunities. Surg Neurol Int. 2013; 4(Suppl 3):S129-35.
PMC: 3654777.
DOI: 10.4103/2152-7806.110661.
View
5.
Sanai N, Berger M
. Glioma extent of resection and its impact on patient outcome. Neurosurgery. 2008; 62(4):753-64.
DOI: 10.1227/01.neu.0000318159.21731.cf.
View